GENSIGHT BIOLOGICS SA (SIGHT.PA) Stock Balance Sheet
Europe - Euronext Paris - EPA:SIGHT - FR0013183985 - Common Stock
0.101 EUR
0 (-0.59%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 270.00K | 2.46M | 2.13M | 10.61M | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 44.29M | |||
| Receivables | 1.40M | 2.00M | 2.44M | 3.63M | 4.63M | |||
| Other Current Assets | 1.04M | 874.00K | 1.95M | 8.70M | 4.44M | |||
| Total Current Assets | 2.71M | 5.34M | 6.53M | 22.95M | 53.36M | |||
| Non-Current Assets | ||||||||
| PPE Net | 695.00K | 933.00K | 2.02M | 2.27M | 2.55M | |||
| Investments And Advances | 3.90M | 4.42M | 502.00K | 632.00K | 624.00K | |||
| Intangibles | 38.00K | 57.00K | 75.00K | 93.00K | 112.00K | |||
| Other Non-Current Assets | 1.00K | -1.00K | 1.00K | 1.00K | N/A | |||
| Total Non-Current Assets | 4.64M | 5.41M | 2.60M | 2.99M | 3.29M | |||
| TOTAL ASSETS | 7.35M | 10.76M | 9.13M | 25.94M | 56.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 13.96M | 13.90M | 17.38M | 2.43M | 5.41M | |||
| Accrued Expenses | 2.65M | 1.90M | 1.81M | 3.64M | 2.48M | |||
| Accounts Payable | 8.56M | 6.36M | 5.63M | 7.81M | 11.56M | |||
| Other Current Liabilities | 452.00K | 459.00K | 462.00K | 764.00K | 2.79M | |||
| Total Current Liabilities | 25.62M | 22.62M | 25.29M | 14.64M | 22.24M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.06M | 5.21M | 6.16M | 15.43M | 12.10M | |||
| Other Non-Current Liabilities | 8.78M | 9.84M | 8.39M | 11.15M | 6.32M | |||
| Total Non-Current Liabilities | 13.84M | 15.06M | 14.54M | 26.58M | 18.42M | |||
| TOTAL LIABILITIES | 39.46M | 37.68M | 39.83M | 41.22M | 40.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -243.15M | -236.65M | -223.27M | -197.65M | -166.34M | |||
| Additional Paid In Capital | 207.76M | 206.61M | 190.94M | 181.21M | 181.18M | |||
| Common Shares | 3.29M | 3.12M | 1.63M | 1.16M | 1.16M | |||
| Other Shareholders' Equity | N/A | N/A | -1.00K | 1.00K | -1.00K | |||
| Shares Outstanding | 131.07M | 124.32M | 64.97M | 46.34M | 46.30M | |||
| Tangible Book Value per Share | -0.25 | -0.22 | -0.47 | -0.33 | 0.34 | |||
| Total Shareholders' Equity | -32.11M | -26.92M | -30.70M | -15.28M | 15.99M | |||
| TOTAL LIABILITIES AND EQUITY | 7.35M | 10.76M | 9.13M | 25.94M | 56.65M | |||
| Statistics | ||||||||
| Debt/Equity | -0.16 | -0.19 | -0.20 | -1.01 | 0.76 | |||
| Current Ratio | 0.11 | 0.24 | 0.26 | 1.57 | 2.40 | |||
| Return On Assets (ROA) | -205.69% | -130.17% | -287.12% | -106.49% | -50.52% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -178.98% | |||
All data in EUR , ROIC based on taxRate of 0.27